Haleon, Pfizer

Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan said on Wednesday.
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.
Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner
(Reuters) -Pfizer is looking to sell about 700 million ordinary shares in Haleon, its bookrunner J.P. Morgan said on Tuesday, lowering its stake in the British consumer healthcare company to about 7.3% from 15%. The sale represents nearly 7.7% of issued ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale
Pfizer Inc. is offering around 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne toothpaste.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesAs E-Bikes Boom in NYC,
Pfizer Sells GBP 2.50 Bln Of Shares In Haleon
Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare
Pfizer to cut Haleon stake in 700M share sale
Pfizer ( NYSE: PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon ( NYSE: HLN) to lower its stake in the British consumer healthcare giant from about 15.0% to 7.3%, implying a divestment of approximately 7.7% of its issued share capital.
Pfizer pares back Haleon stake in £2.5bn sale
Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares in a £2.5bn sale.
Pfizer to sell 700M ordinary shares of Haleon
Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of
UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale
The latest disposal reduced Pfizer's interest in Haleon to 7.3% from 15%. JPMorgan and Morgan Stanley acted as joint global coordinators and joint bookrunners for the sale. GSK sold its remaining 4.2% holding in Haleon in May last year.
Pfizer Has Sold 700M Haleon Shares
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Why Pfizer sold its $3 billion stake in Haleon
Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million shares priced at 357 pence each,
What To Expect From PFE Stock In 2025?
In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 could turn out.
devdiscourse12h
Jury Hits Bayer with $100 Million Verdict Over PCB Controversy
A Washington jury ordered Bayer to pay $100 million to individuals sickened by toxic PCBs at a Seattle school, marking the latest courtroom challenge for the company. Meanwhile, Pfizer is reducing its ...
Haleon (NYSE:HLN) Cut to Equal Weight at Morgan Stanley
Morgan Stanley downgraded shares of Haleon (NYSE:HLN – Free Report) from an overweight rating to an equal weight rating in a ...
Haleon Pioneers New Era in Pain Management Education at DUPHAT 2025
Haleon unveils new initiative at DUPHAT 2025, offering sophisticated pain management solutions with research and training for ...
devdiscourse20h
EU's Bid to Reform Medical Device Market amidst Trade Tensions
Health news updates include the EU contemplating curbs on Chinese medical device makers, Pfizer reducing its stake in Haleon, toothpaste lawsuits over fluoride, Eli Lilly’s stock drop, biopharma ...
Haleon plc (NYSE:HLN) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Haleon plc (NYSE:HLN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research ...
Haleon downgraded to Market Perform from Outperform at Bernstein
Bernstein downgraded Haleon (HLN) to Market Perform from Outperform.Stay Ahead of the Market:Discover outperforming stocks and invest smarter ...
KamCity2d
Sensodyne Launches New Clinical Repair Range
Haleon’s Sensodyne brand is launching a new Clinical Repair toothpaste range this month, comprising two variants – Deep Clean and Active White.